Cellosaurus logo
expasy logo

Cellosaurus TUBO-P2J (CVCL_2A34)

[Text version]
Cell line name TUBO-P2J
Accession CVCL_2A34
Resource Identification Initiative To cite this cell line use: TUBO-P2J (RRID:CVCL_2A34)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00272.
Characteristics: Metastatic phenotype. Established from metastatic lung nodules in mice implanted with the parent cell line (PubMed=25179116).
Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
Transformant: Activated Erbb2/neu.
Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
Disease Malignant neoplasms of the mouse mammary gland (NCIt: C21678)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB-neuT transgenic.
Hierarchy Parent: CVCL_2A33 (TUBO [Mouse mammary tumor])
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
Publications

Patent=KR101309902B1
Park S., Seo S.-K., Bae S.K., Choi J.-H., Jeong H., Park J.-H., Kim T.O., Park S.-J.
Metastatic breast cancer cell line TUBO-P2J.
Patent number KR101309902B1, 17-Sep-2013

PubMed=25179116; DOI=10.1186/1471-2407-14-647; PMCID=PMC4161915
Song H., Kim T.O., Ma S.Y., Park J.-H., Choi J.-H., Kim J.-H., Kang M.S., Bae S.K., Kim K.H., Kim T.H., Seo S.-K., Choi I.W., Song G.A., Mortenson E.D., Fu Y.-X., Park S.
Intratumoral heterogeneity impacts the response to anti-neu antibody therapy.
BMC Cancer 14:647.1-647.12(2014)

Cross-references
Encyclopedic resources Wikidata; Q54973346
Entry history
Entry creation22-Sep-2015
Last entry update19-Dec-2024
Version number8